Cytokinetics Inc annual earnings per share (EPS) for fiscal TTM was $-7.21, a decrease of 10.2% from $-6.54 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-7.21 | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 | $-1.97 | $-2.11 | $-1.95 | $-2.59 | $0.39 | $-0.97 | $-0.41 | $-1.24 | $-2.30 | $-4.06 | $-4.61 | $2.54 | $-6.85 | $-6.16 | $-9.36 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-1.50 | $-1.67 | $-1.49 | $-2.55 | $-1.12 | $-1.36 | $-1.27 | $-1.36 | $-1.31 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More CYTK metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All CYTK financial statements → Interactive CYTK charts →
About TickerBase · Data methodology & sources · Privacy · Terms